Eventide Healthcare & Life Sciences Fund CLASS I SHARES (ETIHX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
33.33
-0.43 (-1.27%)
Jun 18, 2025, 8:05 AM EDT
-1.27%
Fund Assets 1.07B
Expense Ratio 1.32%
Min. Investment $100,000
Turnover n/a
Dividend (ttm) n/a
Dividend Yield n/a
Dividend Growth n/a
Payout Frequency n/a
Ex-Dividend Date n/a
Previous Close 33.76
YTD Return 0.21%
1-Year Return -1.27%
5-Year Return -13.37%
52-Week Low 26.90
52-Week High 38.04
Beta (5Y) 0.64
Holdings 73
Inception Date Dec 27, 2012

About ETIHX

The investment seeks to provide long-term capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets (plus borrowings for investment purposes) in equity and equity-related securities of companies in the healthcare and life sciences sectors, including common stock, options, preferred stock and convertible debt. It may invest without limitation in securities of companies domiciled outside the United States either directly or through American Depositary Receipts ("ADRs"). The fund may invest in securities of companies of any market capitalization.

Category Health
Stock Exchange NASDAQ
Ticker Symbol ETIHX
Share Class Class I Shares
Index S&P Biotechnology Select Industry TR

Performance

ETIHX had a total return of -1.27% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.17%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol Share Class Expense Ratio
ETNHX Class N Shares 1.52%
ETAHX Class A Shares 1.57%
ETCHX Class C Shares 2.32%

Top 10 Holdings

42.12% of assets
Name Symbol Weight
Verona Pharma plc VRNA 5.62%
US BANK MMDA - USBGFS 9 n/a 5.45%
Insmed Incorporated INSM 5.16%
Guardant Health, Inc. GH 4.58%
Mirum Pharmaceuticals, Inc. MIRM 4.38%
Axsome Therapeutics, Inc. AXSM 4.04%
Blueprint Medicines Corporation BPMC 3.44%
Collegium Pharmaceutical, Inc. COLL 3.44%
Scholar Rock Holding Corporation SRRK 3.42%
Alnylam Pharmaceuticals, Inc. ALNY 2.58%
View More Holdings